C WorldWide Group Holding A S bought a new stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 59,639 shares of the medical equipment provider’s stock, valued at approximately $6,983,000.

Other institutional investors and hedge funds also recently modified their holdings of the company. Bronfman E.L. Rothschild L.P. boosted its stake in shares of Zimmer Biomet Holdings by 25.3% during the second quarter. Bronfman E.L. Rothschild L.P. now owns 827 shares of the medical equipment provider’s stock valued at $106,000 after purchasing an additional 167 shares during the period. Parkside Financial Bank & Trust boosted its stake in shares of Zimmer Biomet Holdings by 3.9% during the second quarter. Parkside Financial Bank & Trust now owns 872 shares of the medical equipment provider’s stock valued at $112,000 after purchasing an additional 33 shares during the period. BB&T Investment Services Inc. purchased a new stake in shares of Zimmer Biomet Holdings during the second quarter valued at $144,000. IHT Wealth Management LLC boosted its stake in shares of Zimmer Biomet Holdings by 28.4% during the first quarter. IHT Wealth Management LLC now owns 1,158 shares of the medical equipment provider’s stock valued at $139,000 after purchasing an additional 256 shares during the period. Finally, Sandy Spring Bank boosted its stake in shares of Zimmer Biomet Holdings by 5.4% during the second quarter. Sandy Spring Bank now owns 1,288 shares of the medical equipment provider’s stock valued at $166,000 after purchasing an additional 66 shares during the period. 85.80% of the stock is owned by hedge funds and other institutional investors.

A number of analysts have recently issued reports on the stock. Piper Jaffray Companies lowered shares of Zimmer Biomet Holdings from an “overweight” rating to a “neutral” rating in a research note on Thursday, November 2nd. Oppenheimer Holdings, Inc. set a $137.00 target price on Zimmer Biomet Holdings and gave the company a “buy” rating in a research report on Monday, August 14th. Jefferies Group LLC reiterated a “buy” rating and issued a $136.00 price objective on shares of Zimmer Biomet Holdings in a research note on Friday, November 3rd. Edward Jones upgraded Zimmer Biomet Holdings from a “hold” rating to a “buy” rating in a research note on Thursday. Finally, Stifel Nicolaus restated a “hold” rating and set a $120.00 target price on shares of Zimmer Biomet Holdings in a research note on Friday, November 3rd. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Zimmer Biomet Holdings currently has a consensus rating of “Hold” and an average price target of $134.00.

Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded down $1.09 on Friday, reaching $110.75. The company’s stock had a trading volume of 973,400 shares, compared to its average volume of 1,738,246. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.78 and a current ratio of 1.47. Zimmer Biomet Holdings, Inc. has a one year low of $95.63 and a one year high of $133.49. The stock has a market capitalization of $22,423.88, a P/E ratio of 13.72, a price-to-earnings-growth ratio of 1.72 and a beta of 1.17.

Zimmer Biomet Holdings (NYSE:ZBH) last issued its quarterly earnings data on Wednesday, November 1st. The medical equipment provider reported $1.72 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $1.74 by ($0.02). Zimmer Biomet Holdings had a net margin of 8.36% and a return on equity of 16.29%. The company had revenue of $1.82 billion during the quarter, compared to analysts’ expectations of $1.83 billion. During the same quarter in the prior year, the company earned $1.79 earnings per share. The firm’s revenue was down .8% compared to the same quarter last year. equities analysts anticipate that Zimmer Biomet Holdings, Inc. will post 8.03 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: This story was originally published by Watch List News and is owned by of Watch List News. If you are viewing this story on another domain, it was illegally copied and republished in violation of US and international copyright and trademark law. The legal version of this story can be accessed at https://www.watchlistnews.com/c-worldwide-group-holding-a-s-invests-6-98-million-in-zimmer-biomet-holdings-inc-zbh/1698321.html.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.